文献速递心律失常

不确定潜能的克隆性造血伴Tet2缺失通过Nlrp3炎症小体激活增加房颤风险

Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
PubMed 文献 · Circulation · 2024-02-15

该研究利用UK Biobank分析发现CHIP尤其是TET2 CHIP与房颤发生相关,并在小鼠模型中证实造血细胞Tet2缺失通过Nlrp3炎症小体激活和钙处理异常增加房颤易感性,抑制Nlrp3可预防房颤。

要点

  • UK Biobank显示CHIP尤其TET2 CHIP与房颤发生增加相关。
  • 小鼠造血细胞Tet2缺失通过Nlrp3炎症小体激活和钙处理异常致房颤。
  • Nlrp3失活可预防Tet2缺失小鼠的房颤易感性。

核心结论

  • 在UK Biobank人群中,CHIP尤其是TET2 CHIP与房颤发生存在适度关联。
  • 小鼠造血细胞Tet2缺失通过Nlrp3炎症小体依赖性钙处理异常增加房颤易感性。

研究设计与样本

  • UK Biobank中分析CHIP患病率及房颤发生,按CHIP状态和克隆大小分层使用Cox比例风险模型。
  • 致死照射小鼠接受造血特异性Tet2缺失、Tet2和Nlrp3双缺失或野生型对照骨髓移植,喂食西方饮食6至9周,部分联合NLRP3抑制剂NP3-361。
  • 进行在体侵入性电生理检查和离体光学标测。
  • 分离Ldlr-/-小鼠(造血特异性Tet2缺失或野生型对照,西方饮食)心肌细胞评估钙信号动力学。
  • 多能干细胞来源心房心肌细胞与Tet2缺陷骨髓来源巨噬细胞、野生型对照或细胞因子IL-1β或IL-6共培养。

主要发现

  • UK Biobank分析显示CHIP个体尤其TET2 CHIP者房颤发生增加。
  • 小鼠造血特异性Tet2失活增加致动脉粥样硬化和非致动脉粥样硬化模型房颤倾向,伴Nlrp3表达增加和CaMKII激活。
  • Nlrp3失活可预防Tet2缺失小鼠的房颤易感性。
  • Ldlr-/-小鼠造血Tet2失活后心肌细胞肌浆网钙释放受损,促进房性心律失常。
  • Tet2缺陷巨噬细胞或IL-1β或IL-6共培养可重现肌浆网钙释放异常。

临床怎么用

  • TET2 CHIP个体可能需关注房颤风险,但研究未提供具体筛查或预防建议。
  • NLRP3抑制对TET2 CHIP个体的治疗潜力尚需进一步研究。

局限性

  • UK Biobank中CHIP与房颤关联仅为适度。
  • 机制主要来自小鼠模型和离体细胞实验,人类直接证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovascular disease. Although CHIP is known to increase the risk of myocardial infarction and heart failure, the influence of CHIP in cardiac arrhythmias, such as atrial fibrillation (AF), is less explored. METHODS: CHIP prevalence was determined in the UK Biobank, and incident AF analysis was stratified by CHIP status and clone size using Cox proportional hazard models. Lethally irradiated mice were transplanted with hematopoietic-specific loss of Tet2, hematopoietic-specific loss of Tet2 and Nlrp3, or wild-type control and fed a Western diet, compounded with or without NLRP3 (NLR [NACHT, LRR {leucine rich repeat}] family pyrin domain containing protein 3) inhibitor, NP3-361, for 6 to 9 weeks. Mice underwent in vivo invasive electrophysiology studies and ex vivo optical mapping. Cardiomyocytes from Ldlr-/- mice with hematopoietic-specific loss of Tet2 or wild-type control and fed a Western diet were isolated to evaluate calcium signaling dynamics and analysis. Cocultures of pluripotent stem cell-derived atrial cardiomyocytes were incubated with Tet2-deficient bone marrow-derived macrophages, wild-type control, or cytokines IL-1β (interleukin 1β) or IL-6 (interleukin 6). RESULTS: Analysis of the UK Biobank showed individuals with CHIP, in particular TET2 CHIP, have increased incident AF. Hematopoietic-specific inactivation of Tet2 increases AF propensity in atherogenic and nonatherogenic mouse models and is associated with increased Nlrp3 expression and CaMKII (Ca2+/calmodulin-dependent protein kinase II) activation, with AF susceptibility prevented by inactivation of Nlrp3. Cardiomyocytes isolated from Ldlr-/- mice with hematopoietic inactivation of Tet2 and fed a Western diet have impaired calcium release from the sarcoplasmic reticulum into the cytosol, contributing to atrial arrhythmogenesis. Abnormal sarcoplasmic reticulum calcium release was recapitulated in cocultures of cardiomyocytes with the addition of Tet2-deficient macrophages or cytokines IL-1β or IL-6. CONCLUSIONS: We identified a modest association between CHIP, particularly TET2 CHIP, and incident AF in the UK Biobank population. In a mouse model of AF resulting from hematopoietic-specific inactivation of Tet2, we propose altered calcium handling as an arrhythmogenic mechanism, dependent on Nlrp3 inflammasome activation. Our data are in keeping with previous studies of CHIP in cardiovascular disease, and further studies into the therapeutic potential of NLRP3 inhibition for individuals with TET2 CHIP may be warranted.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lin AE, Bapat AC, Xiao L, et al. Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation. Circulation. 2024. PMID: 38357791. doi:10.1161/CIRCULATIONAHA.123.065597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。